New treatment option for Sleep
Official title I-SLEPT: Integrated Sleep and Life Engagement Program for Transitions
ClinicalTrials.gov ID: NCT07317336
What this study is testing
- What it's testing
- Sleep is essential to functional recovery in rehabilitation settings; however, sleep is likely to be disrupted during rehabilitation admissions. Adverse effects of these disruptions do not subside after discharge, leading to additional consequences such as poor physical function.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- Admitted to and discharged from VA Boston Community Living Center subacute rehabilitation
- English-speaking
- Discharged to a home setting
- Has capacity and does not have severe cognitive impairment
- Obtains a score \>= 8 on the Brief Interview for Mental Status (BIMS)
You likely can't join if
- Discharged from Long-Term Care, Hospice and Palliative Care, or Spinal Cord Injury bed specialty
- Moderate to severe dementia diagnosis, delirium, or active psychosis
- Healthcare proxy is activated in electronic health record
- A diagnosis of a disorder of hypersomnolence, non-REM parasomnia, or Nightmare Disorder as indicated in electronic health record
- High acute risk for suicide
See the full eligibility criteria
- Admitted to and discharged from VA Boston Community Living Center subacute rehabilitation
- English-speaking
- Discharged to a home setting
- Has capacity and does not have severe cognitive impairment
- Obtains a score \>= 8 on the Brief Interview for Mental Status (BIMS)
- Endorses at least 2 items as "Rarely/Never" or "Sometimes" on the RuSATED measure AND/OR endorses they are achieving their goals at a "much worse" or "a little worse" level on the What Matters Most Tool.
- Discharged from Long-Term Care, Hospice and Palliative Care, or Spinal Cord Injury bed specialty
- Moderate to severe dementia diagnosis, delirium, or active psychosis
- Healthcare proxy is activated in electronic health record
- A diagnosis of a disorder of hypersomnolence, non-REM parasomnia, or Nightmare Disorder as indicated in electronic health record
- High acute risk for suicide
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.